Literature DB >> 12691210

Negative experiences on Ecstasy: the role of drug, set and setting.

Karen McElrath1, Kieran McEvoy.   

Abstract

Similar to other sociological studies of Ecstasy use, the authors' research suggests that Ecstasy users tend to report positive effects of the drug. However, we also observed that most users experienced at least one adverse psychological outcome while using Ecstasy. The present study examines those negative experiences within the context of drug, set and setting. Data were collected through in-depth interviews with 98 current or former users of Ecstasy. The results indicate that, in general, negative experiences with Ecstasy did not deter people from using the drug again. The findings suggest that most negative experiences with Ecstasy can be attributed to the interaction between two or more factors, nearly always involving set or setting. Although various analyses have shown that the same "brand" of Ecstasy can contain varying degrees of MDMA, other drugs and adulterants, results from the present study suggest that users' expectations of the drug's effects appear to be related to the brand or label of Ecstasy that is consumed. The role of individual disposition in producing negative drug experiences is less clear; it is possible that this factor might interact with user set or friends' set in contributing to the overall drug experience.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12691210     DOI: 10.1080/02791072.2002.10399954

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  11 in total

1.  Understanding recreational ecstasy use in the United States: a qualitative inquiry.

Authors:  Masuma Bahora; Claire E Sterk; Kirk W Elifson
Journal:  Int J Drug Policy       Date:  2008-02-20

2.  Weekend Ecstasy use disrupts memory in rats.

Authors:  Leah M McAleer; Timothy Schallert; Christine L Duvauchelle
Journal:  Neurosci Lett       Date:  2013-05-22       Impact factor: 3.046

3.  The role of setting in the oral self-administration of alcohol in the rat.

Authors:  Arianna Testa; Paolo Nencini; Aldo Badiani
Journal:  Psychopharmacology (Berl)       Date:  2011-02-11       Impact factor: 4.530

4.  Heat increases MDMA-enhanced NAcc 5-HT and body temperature, but not MDMA self-administration.

Authors:  Allison A Feduccia; Nundhun Kongovi; Christine L Duvauchelle
Journal:  Eur Neuropsychopharmacol       Date:  2010-12       Impact factor: 4.600

5.  What's in a label? Ecstasy sellers' perceptions of pill brands.

Authors:  Micheline Duterte; Camille Jacinto; Paloma Sales; Sheigla Murphy
Journal:  J Psychoactive Drugs       Date:  2009-03

6.  Towards an Explanation of Subjective Ketamine Experiences among Young Injection Drug Users.

Authors:  Stephen E Lankenau; Bill Sanders; Jennifer Jackson Bloom; Dodi Hathazi
Journal:  Addict Res Theory       Date:  2008

7.  Drug context differently regulates cocaine versus heroin self-administration and cocaine- versus heroin-induced Fos mRNA expression in the rat.

Authors:  Michele Celentano; Daniele Caprioli; Pasqua Dipasquale; Pasqua Di Pasquale; Veronica Cardillo; Paolo Nencini; Silvana Gaetani; Aldo Badiani
Journal:  Psychopharmacology (Berl)       Date:  2009-01-24       Impact factor: 4.530

8.  Relationship among subjective responses, flavor, and chemical composition across more than 800 commercial cannabis varieties.

Authors:  Alethia de la Fuente; Federico Zamberlan; Andrés Sánchez Ferrán; Facundo Carrillo; Enzo Tagliazucchi; Carla Pallavicini
Journal:  J Cannabis Res       Date:  2020-07-17

9.  No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation.

Authors:  Kim P C Kuypers; Rafael de la Torre; Magi Farre; Samanta Yubero-Lahoz; Isabel Dziobek; Wouter Van den Bos; Johannes G Ramaekers
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

10.  Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders.

Authors:  Lukas Andreas Basedow; Sören Kuitunen-Paul; Melina Felicitas Wiedmann; Veit Roessner; Yulia Golub
Journal:  Eur J Psychotraumatol       Date:  2021-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.